Caption Management’s Mural Oncology MURA Stock Holding History

Caption Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100,000	Closed	-$126K	–	1734
2025 Q1	$126K	Buy	+100,000	New	+$365K	﹤0.01%	1332

Other funds holding MURA

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caption Management's MURA Position: Q2 2025 in Review

Caption Management sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 73,065 shares — an estimated $92.1K sold.

Caption Management first reported a position in MURA in Q1 2025 and held it in 1 quarter. The position peaked at $92.1K in Q1 2025. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

Caption Management reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
Caption Management sold 73,065 Mural Oncology shares in Q2 2025, an estimated $92.1K.
Caption Management first reported a position in Mural Oncology in Q1 2025 and held it in 1 quarter.
Caption Management's Mural Oncology position peaked at $92.1K in Q1 2025.
66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.